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Abstract
The East/Central/South African genotype of Chikungunya virus with the E1-A226V mutation
emerged in 2011 in Cambodia and spread in 2012. An outbreak of 190 cases was docu-
mented in Trapeang Roka, a rural village. We surveyed 425 village residents within 3–4
weeks after the outbreak, and determined the sensitivity and specificity of case definitions
and factors associated with infection by CHIKV. Self-reported clinical presentation con-
sisted mostly of fever, rash and arthralgia. The presence of all three clinical signs or symp-
toms was identified as the most sensitive (67%) and specific (84%) self-reported diagnostic
clinical indicator compared to biological confirmation by MAC-ELISA or RT-PCR used as a
reference. Having an indoor occupation was associated with lower odds of infection com-
pared with people who remained at home (adjOR 0.32, 95%CI 0.12–0.82). In contrast with
findings from outbreaks in other settings, persons aged above 40 years were less at risk of
CHIKV infection, likely reflecting immune protection acquired when Chikungunya circulated
in Cambodia before the Khmer Rouge regime in 1975. In view of the very particular history
of Cambodia, our epidemiological data from Trapeang Roka are the first to support the per-
sistence of CHIKV antibodies over a period of 40 years.
Author Summary
After first being identified in the 1950s and spreading from Africa in the 1960s, a new pan-
demic strain of Chikungunya virus emerged in East Africa and the Indian Ocean in 2004–
2005, progressing to Asia. Cases have since been described in previously unaffected territo-
ries, as well as regions where Chikungunya transmission was never interrupted.
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Chikungunya circulated in Cambodia in the 1960s and 1970s until the tragic historical
events that followed the civil war. After nearly 40 years of absence of the virus, the new
pandemic strain was first detected in 2011. We undertook a field investigation of a Chi-
kungunya outbreak in Cambodia in 2012. The usefulness of clinical signs for diagnosis of
infection is discussed. Unlike studies from other settings, we show that older age was asso-
ciated with a lower risk of Chikungunya infection, even after behavioural and occupational
factors have been taken into account. This is the first evidence suggesting that infection in
the 1960s and 1970s likely provided long-lasting cross-protection against this new strain.
These findings, which will be further explored in the laboratory, are important to under-
stand immunity against Chikungunya and to predict future epidemics and public health
needs.
Introduction
Chikugunya is caused by an alphavirus transmitted by the bite of Aedesmosquitoes. In
humans, it is mostly a self-limiting illness marked with debilitating joint pains but severe illness
occurs in about 1 clinical case in 1000 [1]. Although it may have circulated since the late 1800s
[2], the chikungunya virus (CHIKV) was first detected in Africa in 1952 [3]. The Asian strain
spread through Asia in the 1960s causing a series of outbreaks throughout the region, including
Cambodia. After several decades of absence, CHIKV re-emerged in the early 2000s [3–5], with
large outbreaks of significant public health concern in Asia and Africa. In 2005, a major epi-
demic in La Réunion island [6] displayed different epidemiological characteristics than previ-
ous outbreaks, with a higher attack rate and causing a number of deaths. Genetic analysis
attributed this outbreak to a mutated strain of the East/Central/South African (ECSA) strain of
CHIKV bearing the E1-A226V and other mutations on the E2 glycoprotein gene [7,8], termed
the Indian Ocean Lineage (IOL) strain [8]. Subsequently, outbreaks of the IOL strain have been
recorded in the Indian Ocean [9–11], South- [12], Southeast- [13–17] and East Asia [18] and
the Pacific [19]. The first outbreak in a temperate country was recorded in 2007 [20], and cases
have been detected in Arabia [21,22]. In 2013, another CHIKV strain, this time of Asian lineage
[23] stormed through the Americas, causing over 1.5 million suspected or confirmed cases to
date [24–27]. That outbreak is still ongoing. Chikungunya poses a real and imminent threat to
all yet unaffected areas where Aedes aegypti or Aedes albopictus are present, including various
regions of Europe [28], the USA [29], Brazil [30] or Australia [31].
Chikungunya re-emerged in Cambodia in 2011 [16], when the IOL strain of CHIKV was
identified, never previously recorded in Cambodia. In this article, we explore the epidemiologi-
cal and clinical characteristics of a 2012 outbreak in Trapeang Roka village of Kampong Speu
province [17], Cambodia, including an analysis of the sensitivity and specificity of clinical signs
and their combination, as well as the association of various factors with the risk of CHIKV
infection.
Methods
Field investigation
The method, dates and duration of the outbreak investigation in Cambodia have been detailed
elsewhere [17]. Briefly, a one-day outbreak investigation was conducted in 2012, three to four
weeks after the onset of the CHIKV outbreak in Trapeang Roka village caused by an ECSA
strain with the E1-A226V mutation, using a standardized, anonymized questionnaire. All
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village residents were eligible for the investigation; consenting individuals were interviewed
regarding socio-demographic characteristics and information on potential risk factors for
exposure and were screened for CHIKV. Participants were asked about self-reported clinical
features (fever, arthralgia and skin rash) using a short questionnaire and the Wong-Baker Pain
Rating scale. For children who were too young to answer, parents/guardians were asked to
answer for the child. Interviews were conducted by teams from the Epidemiology and Public
Health unit of the Institut Pasteur du Cambodge (IPC) and other teams.
Laboratory methods
Dried blood spots were obtained from consenting participants to test for CHIKV IgM [32], as
well as recent infection by dengue (DENV) and Japanese encephalitis B (JEV) viruses using
antibody capture enzyme-linked immunosorbent assay (MAC-ELISA) [33,34]. Participants
with ongoing fever were also tested by quantitative real-time reverse transcriptase PCR
(qRT-PCR) for CHIKV as well as DENV and JEV. Participants (N = 91) with current or very
recent signs or symptoms were also screened for malaria by PCR (all negative). The laboratory
methods used were detailed in the previous report [11].
Statistical / epidemiological analysis
Sensitivity / specificity. Clinical signs or symptoms were tabulated individually and in
combination (the presence/absence of a combination of signs or symptoms) against labora-
tory-confirmed infection with CHIKV through MAC-ELISA or qRT-PCR. The sensitivity,
specificity, positive predictive value (PPV), and negative predictive value (NPV) of individual
and combined signs or symptoms were calculated, to assess their value as diagnostic tools for
CHIKV.
Statistical analysis. Factors associated with CHIKV infection were assessed using random
effects logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CI),
adjusted for correlation/clustering within households. Statistical significance was evaluated
using likelihood-ratio tests (LRTs).
A multivariate model was built adjusting for age as an a priori risk factor. All variables that
associated with CHIKV infection at p<0.15 in the age-adjusted analysis were included in the
multivariate model.
Given the re-emergence of CHIKV in Cambodia, it was considered relevant to explore the
shape of the relationship of participant age with CHIKV infection. The association of age as a
continuous variable with the log odds of CHIKV infection was assessed using fractional poly-
nomials, using a set of defined powers (–2, –1, –0.5, 0.5, 1, 2 and ln(x)) and a maximum of two
power terms in the model. Age was first scaled by dividing by 10 before fitting the models. The
differences in model deviances were compared to select the best model. Predicted log ORs
from each model were transformed into risks through the equation [exp(OR)/(1+exp(OR)],
and predicted probability plots were created from the univariate and multivariate models to
observe associations of age to CHIKV infection. Probability plots from the multivariate model
fixed the other model covariates at their mean values. All analyses were performed using the
STATA 11 statistical package (StataCorp, College station, TX, USA).
Ethics statement
The investigation was undertaken as part of an urgent public health investigation of emerging
CHIKV in Cambodia, with a National Ethics Committee waiver under the authority of the
Ministry of Health. After explaining the investigation in Khmer, participants were asked for
written informed consent to undergo an interview and a fingerprick for blood sampling.
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Participants received advice on how to reduce their risk of CHIKV infection and received their
laboratory results at a later visit. All data collected were anonymised, with no personal
identifiers.
Results
In March 2012, Trapeang Roka consisted of 134 households with 695 inhabitants, mainly rice
field workers and factory workers. All persons who were available on the day of the outbreak
investigation were approached to be interviewed; there were no refusals. In total, 425 partici-
pants (61.1% of the village) from 98 households (73.1%) were surveyed. The global attack rate
was 44.7% (190/425) based on IgM (n = 188) or PCR (n = 2) testing.
Sensitivity and specificity of clinical signs
Findings are presented in Table 1. The combined signs of fever, arthralgia and skin rash was
67% sensitive as a CHIKV diagnostic tool compared to the reference laboratory diagnostic test.
The combination of all three signs or symptoms also identified the highest proportion of labo-
ratory confirmed CHIKV infections during the outbreak (PPV = 77.3%), while those who did
not experience these combination of signs or symptoms represented 76.3% (NPV) of the truly
uninfected. The specificity of individual sign or symptoms, or combination thereof, was higher
than the sensitivity, with between 84.4% to 98.7% of those without the sign or symptom being
correctly identified as CHIKV IgM-negative, depending on which combination of signs or
symptoms was considered.
Association between age and risk of infection
Age was strongly associated with laboratory-confirmed CHIKV infection in both the univariate
and multivariate models (p<0.001); the shape of the association is shown in Fig 1. The pre-
dicted risk of CHIKV peaked at 50% among those age 15 to 26 years (born between 1986 and
Table 1. Self-reported clinical signs of CHIKV E1-A226V infection, and their diagnostic sensitivity/specificity and predictive values, Trapeang
Roka, 2012.
Self-reported clinical signs CHIKV IgM+ (%)* CHKIV IgM—(%) Total p-value from χ2 Test Se* Sp* PPV* NPV*
Fever only Present 12 (6) 26 (11) 38 (9) 0.09 6.4% 89.0% 31.6% 54.5%
Absent 176 (94) 211 (89) 387 (91)
Arthralgia only Present 8 (4) 25 (11) 33 (8) 0.01 4.3% 89.5% 24.2% 54.1%
Absent 180 (96) 212 (89) 392 (92)
Rash only Present 3 (2) 3 (1) 6 (1) 0.79 1.6% 98.7% 50.0% 55.8%
Absent 185 (98) 234 (99) 419 (99)
Fever and Rash Present 4 (2) 5 (2) 9 (2) 0.99 2.1% 97.9% 44.4% 55.8%
Absent 184 (98) 232 (98) 416 (98)
Fever and Arthralgia Present 19 (10) 31 (13) 50 (12) 0.35 10.1% 86.9% 38.0% 54.9%
Absent 169 (90) 206 (87) 375 (88)
Rash and Arthralgia Present 6 (3) 7 (3) 13 (3) 0.88 3.2% 97.0% 46.2% 55.8%
Absent 182 (97) 230 (97) 412 (97)
ALL Present 126 (67) 37 (16) 163 (38) <0.001 67.0% 84.4% 77.3% 76.3%
Absent 62 (33) 200 (84) 262 (62)
Total 188 237 425
*Se: sensitivity; Sp: Speciﬁcity; PPV: positive predictive value; NPV: negative predictive value.
doi:10.1371/journal.pntd.0004281.t001
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1997) and then declined abruptly, reaching a low of 0.1% by age 87. After adjusting for gender
and occupation, the predicted adjusted risk of CHIKV was highest (58%) among 24–32 year-
olds (born between 1980 and 1988).
Other risk factors associated with CHIKV infection
Table 2 shows the association of selected risk factors with laboratory-confirmed CHIKV infec-
tion, none of which showed strong evidence of an association, likely because of the relatively
small sample size. There was some evidence that males were more likely to be infected than
women (adjusted (adj) OR = 1.61; 95%CI 0.93–2.77; p = 0.09). There was also some evidence
of an association with occupation, with CHIKV infection being less likely among participants
who had an indoor occupation compared with those who stayed at home (adjOR 0.32, 95%CI
0.12–0.84, p = 0.07). There was also some evidence that those who had a healthcard–a govern-
ment-issued certificate to allow the poorest Cambodians access to free healthcare–were at
lower risk of infection. There was no evidence of an association of CHIKV infection with level
of education.
Fig 1. Association curve between age and risk of CHIKV infection in univariate analysis and after multivariate analysis, using random effects
logistic regression to account for correlation within households, Trapeang Roka, Cambodia, 2012.
doi:10.1371/journal.pntd.0004281.g001
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Discussion
Our findings show that in a country such as Cambodia that is highly endemic for dengue, the
most sensitive and specific way of clinically diagnosing CHIKV infection based on patients’
self-reported signs is with the simultaneous presentation of fever, joint pain and rash. This clin-
ical case definition of CHIKV can be used to detect outbreaks, especially in age groups not usu-
ally affected by dengue, and for surveillance of epidemic trends. It cannot, however, guide
individual patient management of severe cases or help precisely measure caseload, and may be
of limited use in a setting with seasonal dengue outbreaks. Access to laboratory confirmation is
therefore essential for patient management, for intermittent human and virological surveil-
lance, and to confirm the beginning and end of an outbreak.
Few data are available on the risk factors associated with infection by the ECSA CHIKV
strain, and most previous studies have been conducted in endemic settings or during emer-
gence of the virus. Previous studies have identified older age [6,35,36], gender–male [37] or
female [3,6,38], low education [37], housework [3] and low socio-economic status [37] as main
risk factors for CHIKV infection, although findings vary between studies and populations.
Table 2. The association of selected risk factors to CHIKV infection (after adjusting for age, sex, occupation and healthcard), Trapeang Roka, Cam-
bodia, 2012.
Risk Factors Total CHIKV Positive Crude OR LRT-p-value Adjusted OR § LRT p value
(column %) (row %) (95% CI) (95% CI)§
Total (N = 425) 425 190 (45)
Age
<1 10 (2) 4 (40) <0.001 <0.001
1–5 39 (9) 15 (38)
6–20 153 (36) 83 (54) p1:1.48 (0.72–3.03) 1 p1:3.48 (1.28–9.48) 1
21–40 126 (30) 60 (48) p2:0.99 (0.98–1.00) 1 p2:0.98 (0.98–0.99) 1
41–60 67 (16) 25 (37)
61+ 30 (7) 3 (10)
Sex
Females 236 (56) 91 (39) 1 0.01 1 0.09
Males 189 (44) 99 (52) 1.95 (1.2–3.2) 1.61 (0.93–2.77)
Education
None 118 (28) 38 (32) 1 0.05 1 0.53
Primary 230 (54) 112 (49) 2.09 (1.1–3.9) 1.53 (0.67–3.48)
Secondary or higher 77 (18) 40 (53) 2.03 (0.9–4.5) 1.17 (0.42–3.27)
Occupation
Stay at home 134 (32) 58 (43) 1 0.09 1 0.07
Student 89 (21) 52 (58) 1.82 (0.9–3.8) 1.00 (0.45–2.22)
Outdoor activities 111 (26) 41 (37) 0.72 (0.4–1.4) 0.46 (0.18–1.19)
Indoor activities 91 (21) 39 (43) 0.81 (0.4–1.7) 0.32 (0.12–0.84)
Owning a Healthcard2
No 408 (96) 189 (46) 1 0.02 1 0.04
Yes 15 (4) 1 (7) 0.04 (0.02–0.8) 0.05 (0.00–1.07)
§ OR adjusted for age, sex and occupation and healthcard, from random effects logistic regression to account for correlation within household.
1Best ﬁtting fractional polynomial model for age: p1 = (age/10)0.5; p2 = (age/10)3 2Healthcard: a nominative card issued by the authorities to the poorest
segment of the population to beneﬁt from free healthcare
doi:10.1371/journal.pntd.0004281.t002
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Faced with the large-scale emergence of CHIKV, Cambodian health authorities and their part-
ners invested precious time, effort and scarce resources to document the outbreak in a rural
community setting [17] as well as investigate risk factors for CHIKV infection. In this study in
Trapeang Roka, we found some evidence that males were more likely to be infected by CHIKV.
Occupation also seemed to play a role: indoor activities outside the home (factory work, for
example) seemed to provide protection against CHIKV infection compared to staying at home.
This is likely to be related to a reduction in Aedes aegypti exposure outdoors compared with
people who stay at home and may spend time indoors. A lack of association of occupation with
CHIKV infection has been observed in Mayotte [37], while other studies have observed house-
work as a risk factor [3] or a protective factor for CHIKV [39]. This is likely due to differences
in outbreak settings and environments that determine the presence or absence of CHIKV posi-
tive individuals and the distribution of Aedesmosquitoes.
An elegant study of limited scope conducted in Greece demonstrated that antibodies against
dengue virus can last a lifetime [40]. The duration of immunity conferred by CHIKV infection
is unknown. In our study, villagers younger than 40 were at higher risk of CHIKV infection
after adjustment for other socio-demographic variables, while those over 40 had the lowest risk
of infection. The opposite might have been expected, since older persons tend to remain
around the home so would have higher risk of exposure to Aedesmosquitoes. Furthermore, the
observed age distribution is inverse to what has been shown in all other major outbreaks caused
by the ECSA CHIKV strain, such as those in La Réunion island [6], India [35] or Malaysia
[36], where older age was identified as a strong risk factor for the infection.
The most likely explanation of the age pattern of infection in Trapeang Roka is the presence
of pre-existing antibodies among the older population who were exposed to the Asian CHIKV
lineage during the early 1960s [41–43]. Civil war erupted in Cambodia in 1968 and lasted until
the April 1975 Khmer Rouge takeover and terror regime, during which people were forbidden
to travel [44]. As one of many consequences, large-scale circulation of CHIKV in Cambodia
was no longer detectable [16,17]. The Asian strain of CHIKV continued to circulate in Asia,
especially Thailand [45]. Virological testing for dengue-like syndromes in Cambodia at the
Institut Pasteur du Cambodge was initiated in 2000, and systematically and actively sought but
never detected CHIKV until 2011, when it re-emerged [16]. Our data show that the risk of
CHIKV infection was highest in people who were born since 1975. This provides compelling
evidence that the previously circulating Asian CHIKV lineage very likely provided immune
protection against the new ECSA CHIKV strain bearing the E1-A226V mutation and that this
immunity has persisted for 40 years.
Our study has limitations. For the risk factor analysis, our sample size is small, so our power
to detect significant associations with risk factors is not high. There may be some multicoli-
nearity (redundancy) between the variables of age and occupation, and there may be some
residual confounding because of imperfectly measured variables. Also, the decrease in risk of
CHIKV infection among villagers aged above 40 could be due to behavioral factors that we did
not measure which therefore could not be adjusted for in the analysis. However, the observed
effect is strong, the risk falls rapidly after age 40 (not only in the elderly) and persons of all ages
live in close proximity with very similar lifestyles and exposure to Aedesmosquitoes. The
broad range of risk factors examined in the study would likely have provided a proxy for any
other strong, undocumented exposure. Lastly, some village residents may have been missed as
they were away at work, thereby overestimating the risk among 20–40 year olds. We are confi-
dent, however, that this does not seriously challenge the validity of our data: although the num-
ber of interviews was limited due to the one-day nature of the investigation, all persons
approached agreed to participate and over 60% of residents, worker or not, and 70% of house-
holds, were interviewed and sampled.
Epidemiological Evidence for Lasting Protection against Chikungunya
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For the analysis of the sensitivity and specificity of clinical signs or symptoms, we used self-
declared signs or symptoms rather than those observed by medical staff. There is therefore a
possibility of response bias. Several studies undertaken at the Epidemiology and Public Health
Unit of the Institut Pasteur du Cambodge have shown how labile answers to non-objective
questions (signs or symptoms) can be, to answer the presumed wishes of the interviewer. In
order to minimize this, questionnaires were administered carefully by trained native Khmer-
speaking interviewers. Finally, the sensitivity and specificity of the MAC-ELISA method used
for measuring anti-CHIKV IgM are unknown.
Conclusion
Studies of emergent pathogens in the laboratory or in the hospital setting are very important to
identify risk factors for increased circulation (such as CHIKV mutations [7,8]) or severe clini-
cal forms [1] of infection. However, the findings that will guide surveillance, risk assessment
and public health prevention and response should originate mainly from careful epidemiologi-
cal documentation in the community of the true health burden of disease, risk factors associ-
ated with infection and the performance of clinical case definitions. Our data show that current
case definitions are both sensitive and specific enough to guide initial epidemiological assess-
ments but must be complemented by virological tests performed by experienced laboratories.
Importantly, these data from Cambodia—with its unique and dramatic history—strongly sug-
gest that immunity against CHIKV may last several decades, an important element for future
risk assessment in non-endemic settings and as this virus spreads across the NewWorld and
the Pacific. These epidemiological findings will be verified in the laboratory by testing immu-
nity against the CHIKV strain which circulated in the Mekong Region in the 1960s.
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